Niamh Madigan | 03/26/2013
The Delegated Acts are due to come into force in 2017 and no company, big or small, can be in a position to sit waiting for the specific delegated acts to be released following the falsified medicines directive. The advice is to start pilots now before scaling up, instead of waiting until the last hour. There is temptation to delay doing so because of costs and uncertainity around timing. Christoph Krahenbuhl, Expert at EFPIA, explains to Pharma IQ the key s...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More